Point of Care Testing (POCT) International Normalised Ration (INR), testing, Meter, Reagents, Consumables and Quality Control and POCT Portable Handheld Blood Gas Testing
In plain English
The notice doesn't say
Who holds it now
Last won by Bruker UK Ltd in Sep 2026, for £316k.
- Genotype Testing for MycobacteriumBruker UK Ltd £316k
- Spinal, Blood Collection Needles and Associated ProductsB. Braun Medical Ltd Ireland, Becton, Dickinson U.K. Limited, Crest Medical Limited and 12 more £9.5m
- Treatment & Examination Couches, Chairs & Associated EquipmentArjo UK Limited, John Preston & Co. (Belfast) Limited, Northern Hospital Supplies Limited and 2 more £2.4m
What you're up against
- The last two awards went to different firms: this buyer has changed supplier before.
- 21 different firms won this buyer's 3 awards for this kind of work in 2026.
- It last went for £316k in 2026.
The notice as published
This Preliminary Market Engagement (PME) is being published by the Regional Business Services Organisation (BSO) Procurement and Logistics Service (PaLS) for the purposes of informing and engaging with potential service providers regarding the upcoming public competition for Point of Care Testing (POCT) International Normalised Ratio (INR) Testing and POCT Portable Handheld Blood Gas (HHBG) Testing within Health and Social Care Northern Ireland (HSCNI). The five Buyers within HSCNI, Belfast Health & Social Care Trust (BHSCT), Northern Health & Social Care Trust (NHSCT) Southern Health & Social Care Trust (SHSCT), South Eastern Health & Social Care Trust (SEHSCT) and Western Health & Social Care Trust (WHSCT) require POCT INR testing Devices, Middleware and Connectivity, Reagents, Consumables, Quality Control (Q.C.), Training, Service and Maintenance and External Quality Assurance (EQA). The five Buyers also require POCT portable HHBG testing devices, middleware and connectivity, reagents, consumables, Q.C, training, service and maintenance and EQA.